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Complete Genome Sequence of the Podoviral Bacteriophage YMC/09/
02/B1251 ABA BP, Which Causes the Lysis of an OXA-23-Producing
Carbapenem-Resistant Acinetobacter baumannii Isolate from a Septic
Patient
Jongsoo Jeon,a Jae-won Kim,b Dongeun Yong,a Kyungwon Lee,a and Yunsop Chonga
Department of Laboratory Medicine and Research Institute of Antimicrobial Resistance, Yonsei University College of Medicine, Seoul, South Korea,a and C. J. Cheil Jedang
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The emergence of carbapenem-resistant Acinetobacter baumannii, responsible for causing nosocomial infections, has been be-
coming a significant global health issue. In this article, we report the complete genome sequence of bacteriophage-B1251
(YMC/09/02/B1251 ABA BP), which causes lysis of a carbapenem-resistant A. baumannii strain. The bacteriophage belongs to
the family Podoviridae and has a double-stranded circular DNA genome with a length of 45,364 bp and a 39.05%GC content.
Genome analysis showed that it had no similarity to other previously reported bacteriophages capable of infecting A.
baumannii.
Acinetobacter baumannii causes severe infections, includingsepticemia, in immunocompromised patients (8, 13). Re-
cently, the emergence of multidrug-resistantA. baumannii strains
that are even resistant to carbapenem, the last resort for the treat-
ment of severe Gram-negative bacterial infections, has increased
worldwide concerns (5, 6). In this study, we reveal a novel carbap-
enem-resistant A. baumannii lytic bacteriophage, -B1251
(YMC/09/02/B1251 ABA BP), which was isolated from a sewage
sample obtained from a university hospital in South Korea. The
bacteriophage was purified by the agar double-layer method (6,
12), using an OXA-23-producing carbapenem-resistant A. bau-
mannii strain isolated from a septic patient. It was classified as a
member of the family Podoviridae by using electron microscopy.
The genomic DNA of -B1251 was sequenced using an Illu-
mina Genome analyzer (Illumina, Inc.) with approximately 152-
fold coverage. Gap filling was carried out by using standard PCR
and subsequent Sanger sequencing. The whole-genome sequence
was analyzed by using Newbler assembler 2.3 (Roche), Codon-
CodeAligner (CodonCode, Co.), andCLCGenomicsWorkbench
4.8 (CLCbio). Open reading frames (ORFs) were predicted by the
NCBI ORF Finder (11) and GenMark.hmm (3), and the gene was
annotated by homology searches of the GenBank (2) and Clusters
of Orthologous Groups (COG) (10) databases. Similarity scores
between all putative proteins were determined by PSI-Search
(http://www.ebi.ac.uk/Tools/sss/fasta/) and BLASTP (1). The
prediction of tRNA was identified using the tRNAscan-SE pro-
gram (7).
The genome consists of a double-stranded circular DNAwith a
length of 45,364 bp and a GC composition of 39.05%, with no
tRNAs identified. Among the 62 total putative ORFs, 37 (57%)
indicated hypothetical proteins. Fifty-one ORFs were on the plus
strand and only 11 ORFs on the minus strand. The sequences
appeared to contain three functional groups, as follows: (group 1)
replication and modification (gp1, putative restriction-modifica-
tion protein; gp9 and gp10, putative phage replication proteins),
(ii) DNA package and structure/morphogenesis (gp22, putative
head morphogenesis protein; gp21 and gp25, putative phage
structural proteins; gp27, putative major capsid protein; gp49,
putative tail protein), and (iii) lysis (gp51, putative endolysin).
The sequence did not show similarity to other previously studied
bacteriophages capable of infecting A. baumannii, such as phage
phiAB1 (GenBank accession no. HQ186308), phage AB1 (Gen-
Bank accession no. HM368260), and phage AP22 (GenBank ac-
cession no.HE806280), according to the results from the BLASTN
program(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi/).
Double-stranded DNA phages generally use endolysin to rap-
idly degrade the peptidoglycan cell wall, which consequently
causes lysis of the host bacteria (4, 14). gp51 showed only 51%
identity to the endolysin ofErwiniaphage vB_EamP-S6 (GenBank
accession no. HQ728266).
To the best of our knowledge, -B1251 is a novel bacterio-
phage that can lyse OXA-23-producing carbapenem-resistant A.
baumannii isolates from a septic patient. Strains of this type have
evoked worldwide concern. The bacteriophage could be a useful
strategy for prevention of infections withmultidrug-resistant bac-
teria (5, 9). Therefore, characterization of -B1251 would facil-
itate the development of an alternative tool to control the spread
of multidrug-resistant A. baumannii.
Nuclotide sequence accession number. The complete genomic
sequence of the Acinetobacter bacteriophage -B1251 has been
deposited in GenBank under accession no. JX403940.
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